FDA Approved: RIVASTIGMINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA has approved a supplemental application for rivastigmine from Zydus Pharmaceuticals USA Inc., indicating an approved change to the generic product’s labelin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Parkinson Disease Dementia

Drugs mentioned

• Rivastigmine (Rivastigmine)

Snippet

SUPPL AP for RIVASTIGMINE (RIVASTIGMINE)